Drug Trends and Strategic Insights

Free to International Foundation and ISCEBS members

In recent years, private drug plans have been dominated by specialty drugs, biologics and biosimilars, and more costly treatments for chronic diseases. With regard to these drugs, this session will cover trends and strategies related to:

• Utilization rates in private plans
• Cost-saving measures
• Future insights.